AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 Crore
New Delhi: Drug firm AstraZeneca Pharma India has recently reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018. The company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Company's total revenue for the quarter under consideration stood at Rs 164.71 crore. It was Rs 166.75 crore for the same period year ago.
AstraZeneca Pharma India Limited is the Indian subsidiary of the global biopharmaceutical company AstraZeneca Plc, UK.
Read Also: AstraZeneca’s Diabetic drug Farxiga curbs heart failure, kidney risks